| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |